Brazil: The patent combination conundrum

Patents to new medicines usually protect the active ingredient (compound), provided that it is new and inventive. It is also a common practice for pharmaceutical companies to seek patent protection for drug combinations, which can be especially valuable for providing a competitive advantage over other companies that are developing single-component drugs.